Overview
Pascal Gelebart practices in Bergen, Norway. Mr. Gelebart is rated as an Advanced expert by MediFind in the treatment of Mantle Cell Lymphoma (MCL). His top areas of expertise are Mantle Cell Lymphoma (MCL), Anaplastic Large Cell Lymphoma, Non-Hodgkin Lymphoma, and Choroid Plexus Carcinoma.
His clinical research consists of co-authoring 29 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 7 articles in the study of Mantle Cell Lymphoma (MCL).
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Mantle Cell Lymphoma (MCL)Mr. Gelebart isAdvanced. Learn about Mantle Cell Lymphoma (MCL).
- Experienced
- Acute Myeloid Leukemia (AML)Mr. Gelebart isExperienced. Learn about Acute Myeloid Leukemia (AML).
- Anaplastic Large Cell LymphomaMr. Gelebart isExperienced. Learn about Anaplastic Large Cell Lymphoma.
- Cerebral Ventricle CancerMr. Gelebart isExperienced. Learn about Cerebral Ventricle Cancer.
- Choroid Plexus CarcinomaMr. Gelebart isExperienced. Learn about Choroid Plexus Carcinoma.
- LeukemiaMr. Gelebart isExperienced. Learn about Leukemia.
- Non-Hodgkin LymphomaMr. Gelebart isExperienced. Learn about Non-Hodgkin Lymphoma.